Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis
Both tested doses of ARQ-151 demonstrated statistically significant superiority over vehicle Favorable safety and tolerability in this patient population ARQ-151...